A26 Mrv0541 02231217112D 21 21 0 0 0 0 999 V2000 -0.6729 -0.6437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3874 -1.0562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1019 -0.6437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1019 0.1813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3874 0.5938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6729 0.1813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8163 -1.0562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5308 -1.4687 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 -2.4038 -1.7707 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 -3.2288 -0.3417 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 0.0415 0.5938 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.7560 0.1813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4705 0.5938 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.4705 1.4188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1850 0.1813 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.8994 0.5938 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.1850 -0.6437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7560 -0.6437 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.4705 2.2438 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.9648 0.8858 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2.1850 0.7652 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 0 0 0 1 6 1 0 0 0 0 2 3 1 0 0 0 0 3 4 2 0 0 0 0 3 7 1 0 0 0 0 4 5 1 0 0 0 0 5 6 2 0 0 0 0 6 11 1 0 0 0 0 7 8 1 0 0 0 0 7 9 1 0 0 0 0 7 10 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 12 18 2 0 0 0 0 13 14 1 6 0 0 0 13 15 1 0 0 0 0 13 20 1 1 0 0 0 14 19 3 0 0 0 0 15 16 1 6 0 0 0 15 17 1 0 0 0 0 15 21 1 1 0 0 0 M END > DB03805 > drugbank > [H][C@](C)(O)[C@@]([H])(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F > InChI=1S/C12H11F3N2O2/c1-7(18)10(6-16)11(19)17-9-4-2-8(3-5-9)12(13,14)15/h2-5,7,10,18H,1H3,(H,17,19)/t7-,10-/m1/s1 > InChIKey=YODXEQNROKSLLQ-GMSGAONNSA-N > 3 > 23.61255283561889 > 1 > 2 > 272.077262221 > 0 > C12H11F3N2O2 > 1 > (2R,3R)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]butanamide > 2.01 > 1.7177721240000001 > -3.70 > 272.2231 > 0 > 1 > 0 > 13.063171857374794 > 8.04897593502933 > -3.065096609171502 > 73.12 > 62.9861 > 4 > 1 > 5.40e-02 g/l > (2R,3R)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]butanamide > 0 > DB03805 > experimental > Antiproliferative Agent A771726 $$$$